AU2004270261B2 - Polyamine-metal chelator conjugates - Google Patents

Polyamine-metal chelator conjugates Download PDF

Info

Publication number
AU2004270261B2
AU2004270261B2 AU2004270261A AU2004270261A AU2004270261B2 AU 2004270261 B2 AU2004270261 B2 AU 2004270261B2 AU 2004270261 A AU2004270261 A AU 2004270261A AU 2004270261 A AU2004270261 A AU 2004270261A AU 2004270261 B2 AU2004270261 B2 AU 2004270261B2
Authority
AU
Australia
Prior art keywords
compound
iron
polyamine
group
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004270261A
Other languages
English (en)
Other versions
AU2004270261A1 (en
Inventor
Raymond J. Bergeron Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of AU2004270261A1 publication Critical patent/AU2004270261A1/en
Application granted granted Critical
Publication of AU2004270261B2 publication Critical patent/AU2004270261B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyethers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
AU2004270261A 2003-09-09 2004-09-09 Polyamine-metal chelator conjugates Ceased AU2004270261B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50134103P 2003-09-09 2003-09-09
US60/501,341 2003-09-09
PCT/US2004/029318 WO2005023310A2 (en) 2003-09-09 2004-09-09 Polyamine-metal chelator conjugates

Publications (2)

Publication Number Publication Date
AU2004270261A1 AU2004270261A1 (en) 2005-03-17
AU2004270261B2 true AU2004270261B2 (en) 2008-12-04

Family

ID=34273034

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004270261A Ceased AU2004270261B2 (en) 2003-09-09 2004-09-09 Polyamine-metal chelator conjugates

Country Status (8)

Country Link
US (1) US20080096974A2 (enExample)
EP (1) EP1667727B1 (enExample)
JP (1) JP2007505044A (enExample)
AT (1) ATE400300T1 (enExample)
AU (1) AU2004270261B2 (enExample)
CA (1) CA2538159A1 (enExample)
DE (1) DE602004014949D1 (enExample)
WO (1) WO2005023310A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
WO2005034949A1 (en) 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
TR201910900T4 (tr) 2005-04-04 2019-08-21 Univ Florida Desferritiyokin polieter analogları.
US20090053137A1 (en) * 2006-03-15 2009-02-26 Moore Dennis A Chelating Conjugates Having a Substituted Aromatic Moiety and Derivatives Thereof
WO2008130395A2 (en) * 2006-12-12 2008-10-30 University Of Florida Desferrithiocin analogue actinide decorporation agents
CN101687825B (zh) 2007-03-15 2014-04-23 佛罗里达大学研究基金公司 去铁硫辛聚醚类似物
WO2009055863A1 (en) * 2007-11-01 2009-05-07 The University Of Sydney Desferrioxamine conjugates, derivatives and analogues
US8637312B2 (en) 2008-01-09 2014-01-28 Cellca Gmbh Mammalian culture media with polyamine and iron
US9259670B2 (en) 2008-04-16 2016-02-16 The University Of Kentucky Research Foundation Flow-through filter to remove aluminum from medical solutions
US7932326B2 (en) * 2008-04-16 2011-04-26 The University Of Kentucky Research Foundation Chelating compounds and immobilized tethered chelators
CA2728636A1 (en) 2008-07-14 2010-01-21 Ferrokin Biosciences, Inc. Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
EP2542248A4 (en) 2010-03-02 2013-04-17 Univ Kansas POLYAMINE-DIHYDROXYBENZOIC ACID CONJUGATE HYDROGELES AS IRON-CHELATOR
CA2798082A1 (en) * 2010-05-04 2011-11-10 Shire Llc Desazadesferrothiocin analogues as metal chelation agents
CN104114170B (zh) 2011-12-16 2021-07-06 佛罗里达大学研究基金会 4′-去铁硫素类似物的用途
FR2984317B1 (fr) 2011-12-20 2015-02-27 Univ Rennes Composes chelateurs de metal presentant au moins une chaine polyaminee.
WO2015077655A1 (en) 2013-11-22 2015-05-28 University Of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
JP2018515475A (ja) 2015-04-27 2018-06-14 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． 代謝的にプログラムされた金属キレーターおよびその使用
IL262620B2 (en) * 2016-04-29 2024-02-01 Ophirex Inc PLA2 and HMG-COA suppressors for the treatment of pathological diseases that cause hemolysis, brain edema and acute kidney injury
WO2020092464A1 (en) 2018-10-30 2020-05-07 The Research Foundation For The State University Of New York Compositions and methods for removal of negatively charged impurities using metal-cellulose fiber composite

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5342945A (en) * 1986-12-02 1994-08-30 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US6184232B1 (en) * 1986-12-02 2001-02-06 University Of Florida Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment
US5554748A (en) * 1989-04-07 1996-09-10 Nycomed Salutar, Inc. Adducts of macrocyclic chelants
WO1993004036A1 (en) * 1991-08-23 1993-03-04 Pfizer Inc. Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists
US5493053A (en) * 1994-12-21 1996-02-20 University Of Florida Research Foundation, Inc. Method for preparing desferrioxamine B and homologs thereof
US5886051A (en) * 1995-11-08 1999-03-23 University Of Florida Research Foundation, Inc. Methods and compositions for the treatment of neurodegeneration
US5739395A (en) * 1997-01-10 1998-04-14 University Of Florida Research Foundation, Inc. Method for synthesis of rhizoferrin
JP2001512502A (ja) * 1997-01-21 2001-08-21 ナイコメッド・アマーシャム・ピーエルシー 標識した因子Ｘ▲ＩＩＩ▼ａ基体
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2003263948A1 (en) * 2002-08-22 2004-03-11 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Bergeron et al (1984) Biochem Biophys Res Comm 121 848-854 *
Bergeron et al (1995) J Med Chem 38 2278-2285 *
Bergeron et al (Mar 2003) J Med Chem 46 1470-1477 *
Bergeron et al (Nov 2003) J Med Chem 46 5478-5483 *
Delcros et al (2002) J Med Chem 45 5098-5111 *
Hnatowich et al (1982) Int J Appl Rad Isotops 33 327-332 *
Kontoghiorghes et al (Aug 2004) Curr Med Chem 11 2161-2183 *
Martin et al (2001) J Med Chem 44 3653-3664 *
Safavy et al (2002) Bioconjug Chem 13 317-326 *
Wang et al (Jun 2003) J Med Chem 46 2672-2682 *

Also Published As

Publication number Publication date
DE602004014949D1 (de) 2008-08-21
ATE400300T1 (de) 2008-07-15
WO2005023310A3 (en) 2005-04-21
EP1667727B1 (en) 2008-07-09
AU2004270261A1 (en) 2005-03-17
JP2007505044A (ja) 2007-03-08
US20080096974A2 (en) 2008-04-24
EP1667727A2 (en) 2006-06-14
WO2005023310A2 (en) 2005-03-17
US20060211773A1 (en) 2006-09-21
CA2538159A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
AU2004270261B2 (en) Polyamine-metal chelator conjugates
US6391895B1 (en) Nitric oxide releasing chelating agents and their therapeutic use
Raymond et al. Complexation of iron by siderophores a review of their solution and structural chemistry and biological function
Liu et al. Design of iron chelators with therapeutic application
US5840759A (en) Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
US5837736A (en) Nitric oxide-releasing compounds to sensitive cancerous cells to chemotherapeutic agents
EP2648766B1 (en) Psma-targeted dendrimers
CN110177581B (zh) 髓过氧化物酶显像剂
US8822541B2 (en) Use of targeted nitroxide agents in mitigating or treating radiation injury
WO2002010142A1 (en) Cyclic polyamine compounds for cancer therapy
WO1993021151A1 (en) Substituted thioureas as bifunctional chelators
AU2001278143A1 (en) Cyclic polyamine compounds for cancer therapy
US10842893B2 (en) Multifunctional chelators, complexes, and compositions thereof, and methods of using same
US20100273847A1 (en) Desferrioxamine conjugates, derivatives and analogues
Santos et al. Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: Synthesis, complexation with Fe (III), Al (III) and Ga (III) and in vivo evaluation with 67Ga
HK1245276B (zh) 新化学实体钙锰福地吡和其他混合金属配合物、制备方法、组合物以及治疗方法
US20140364454A1 (en) Metal-chelating compounds having at least one polyamino chain
MX2012000303A (es) Composiciones farmaceuticas y metodos teraputicos que emplean una combinacion de un compuesto complejo de manganeso y una forma compleja no de manganeso del compuesto.
EP3011976A1 (en) 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents
WO2007040535A1 (en) Use of polyamine analogs for treatment and prevention of intestinal polyps
US20090143456A1 (en) Polyamine Analogs as Modulators of Cell Migration and Cell Motility
JP6174600B2 (ja) 錯体形成化合物
US20230031576A1 (en) Radiolabelled targeting ligands
CN119569610B (zh) 一种偕胺肟类多齿配体及其制备方法和应用
WO2008112251A1 (en) Cyclopropyl-containing polyamine analogs as disease therapies

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired